SURFACE MODIFICATION OF ENDOVASCULAR DEVICES  
UCLA Technology Available For Licensing

Investigators at UCLA have discovered a technique to make a metal surface superhydrophilic, which could reduce the friction of any interventional metal devices during their deliveries. The treatment of NiTi or CoCr stent with a type of light causes the metal device to become hydrophilic, also increasing the affinity between the metal device and vascular tissue.

BACKGROUND:  Current endovascular procedures for the treatment of vascular diseases use a number of metallic devices including guidewires, stents and coils. A popular material for these metallic devices is NiTi and CoCr. Although this material is commonly used, it has several limitations. First, the device generates friction during the installation procedure as the device rubs against the plastic catheter used during installation. A second problem is that once a metal device is placed in an artery, the patient needs to be on blood thinning medications for a long time. This problem can be mitigated by covering the device with native tissues and cells.

INNOVATION:  Researchers at UCLA have discovered a method of treating Nitinol sheets, wires, or stents that overcomes the limitations of these devices in current practice. The devices are treated with a type of light, causing them to take on super hydrophilic properties. This conversion increases the affinity between the device and vascular tissue, resulting in the acceleration of the healing process and a reduction in clotting. The hydrophilic device also demonstrates less friction during insertion or delivery.

POTENTIAL APPLICATIONS 

ADVANTAGES

DEVELOPMENT-TO-DATE:  NiTi and CrCo samples were treated a type of light and demonstrated to convert to hydrophilic properties. After the conversion, the NiTi sheet with hydrophilic conversion showed faster endothelial migration and faster healing that the sheet without conversion.

Reference: UCLA Case No. 2008-007

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla08-007.htm

Lead Inventor: Satoshi Tateshima

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2009 The Regents of the University of California.

keywords: medical device, cardiovascular, treatment, endoscopy, device, Nitinol, NiTi, Cobalt Chromium, CrCo, stent, wire, sheet uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card